Recalls for ‘supplement’ with hidden Viagra API
A Florida company is recalling 26 sexual enhancement and diet pills after the US FDA discovered some contain undeclared active pharmaceutical ingredients (APIs).
Archives for September 14, 2015
Parexel: M&A likely to continue despite $200m stock repurchase plan
Parexel could repurchase up to $200m (€175m) of its stock in FY 2016, but one analyst says the firm remains committed to it M&A strategy.
Medidata trial data tech to benefit from regulatory demands, analyst
A favourable regulatory environment encouraged by the 21st Century Cures Act will help drive CRO demand for Medidata’s cloud-based technologies, according to a Citi analyst.
Supersonic spray will transform bioavailability, says BASF
BASF is developing extra-soluble nanoparticles for better drug delivery using faster-than-sound technology.
Unilife cuts workforce by 17% as it shifts from R&D to commercialisation
Unilife has axed about 50 R&D jobs as part of a plan to reduce its operating expenses.
Midatech revenues up 800% on gold nanoparticle drug conjugate tech
Midatech’s gold nanoparticle (GNP) drug conjugate technology and recent acquisitions are helping transfer the firm into a speciality pharma company, an analyst says.